TNX-1700
Tonix Pharmaceuticals
[]
today, $tnxp announced the presentation of two posters with research results on tnx-1700 (recombinant tff2 albumin fusion peptide) at the annual meeting, held april 14-19, 2023, in orlando, fl. posters: 
Tonix Pharmaceuticals strives to be a leader in providing novel drug therapies and vaccines to improve population health around the world